http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI9911178-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e673458c8c443e6fcd34bbc9565bf7f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
filingDate 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e65588fdde58f464676d848d224a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96f0ea58e00027c33ce72dc24619e6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43f94ef9f14eb540e1d3b935a10ec3b
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI9911178-C1
titleOfInvention derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems, as well as pharmaceutical preparation and use thereof
abstract patent:<b>"derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems"<d>. The present invention relates to novel compounds of formula (I) wherein R1 is hydrogen, C1-6-alkyl, optionally substituted by fluorine, or C3-6-cycloalkyl; R2 is hydrogen or a group selected from -ch2c(=chr)-coor, -ch2ocor, -ch(r)ocor, -ch(r)ocoor, -ch(ocor) ocor, -cr 2 -coch 2 -ocor and (ii); r3 is hydrogen or a group selected from -ch2c(=ch2c)-coor, -cooch2c(=chr)-coor, -cooch-2ocor, -cooch(r )ocor, -cooch(r)ocoor, -cooch(ocor)ocor, -cooch~ 2~coch~ 2~ocor, and (iii); with the proviso that one of R2 and R3 is hydrogen and the other of R2 and R3 is other than hydrogen, R is hydrogen or C1-6-alkyl; R4 is hydrogen or hydroxy, R5 is hydrogen or <sym>-hydroxyalkyl; ex is ch or n, as well as to pharmaceutically acceptable salts of said compounds and hydrates of said compounds and their salts, and to the use of compounds of formula (I) and pharmaceutically acceptable salts of said compounds and hydrates of said compounds and of their salts for the manufacture of pharmaceutical preparations containing such compounds.
priorityDate 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508

Total number of triples: 24.